DBV Technologies
Allergy expert Dr Hugh Sampson joing DBV Technologies
July 9, 2015Research and Development DBV Technologies, Viaskin
DBV Technologies has appointed Dr Hugh Sampson as its chief scientific officer. The French biotech company is developing the Viaskin peanut allergy treatment patch. Dr …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
